Sort by
Refine Your Search
-
Listed
-
Field
-
. Applicants should possess a Ph.D. degree in chromatin biology, epigenetics, structural biology, cell biology, or a related field, and demonstrate exceptional experimental, writing, and communication abilities
-
communication abilities. Preference will be given to candidates with research experience in structural biology and molecular biology. In particular, we seek applicants with expertise in techniques relevant
-
. Applicants should possess a Ph.D. degree in Cancer Biology, Cancer Immunology, Biomedical Sciences or a related field, and demonstrate exceptional experimental, writing, and communication abilities. Preference
-
the possibility of renewal subject to satisfactory performance. Applicants should have a Ph.D. in bioinformatics, genetics, computational biology or other relevant disciplines, and in-depth experience with at least
-
the possibility of renewal subject to funding availability and satisfactory performance) Applicants should possess a doctoral degree (Ph.D.) in Stem Cell Biology, Molecular Biology, Developmental Biology, or a
-
: (1) Chemical biology; (2) Anticancer drug research; (3) Cancer biology; (4) Mass spectrometry; (5) Proteomics. They should be self-motivated, responsible and able to work independently as well as in a
-
, molecular and cell biology, and animal models. Skills in bioinformatics are advantageous. Candidates should be highly motivated and have a track record of publications in international journals. The appointee
-
Biology, Immunology, or a related discipline. Experience in cancer research using various animal tumor models would be an advantage. The appointee will work together with a research and development team
-
Biology, Biomedical Sciences, or a related discipline. Experience in animal research would be an advantage. The appointee will work together with a research and development team focusing on Immunology and
-
Ph.D. degree, preferably in Biological Science, Biomedical Science or other related disciplines Extensive experience in stem cell culture, gene-editing and CRISPR-Cas9 system Strong leadership experience